eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | antiphospholipid syndrome |
| Comorbidity | C0000786|miscarriage |
| Sentences | 5 |
| PubMedID- 24040195 | In women with recurrent miscarriage and a diagnosis of antiphospholipid syndrome (aps), treatment with aspirin and heparin has been suggested to improve the pregnancy outcome, although findings from available randomized trials have been inconsistent [11], [12], [13]. |
| PubMedID- 20393166 | Antiphospholipid antibodies (apl) represent an important risk factor for thrombosis and recurrent miscarriage in patients with antiphospholipid syndrome (aps). |
| PubMedID- 20795446 | This retrospective review of hospital records analysed pregnancy outcome with 2 different treatments for women with recurrent miscarriage diagnosed with antiphospholipid syndrome in the index pregnancy. |
| PubMedID- 20378110 | antiphospholipid syndrome patients with recurrent miscarriage have an impairment in fibrinolysis demonstrated by prolonged clot lysis time (clt) that cannot be attributed to differences in thrombin activatable fibrinolysis inhibitor (tafi) antigen levels. |
| PubMedID- 21792337 | Small-scale trials investigating the use of aspirin in the prevention of recurrent miscarriage in women without antiphospholipid syndrome have so far found little benefit;88 however, the findings regarding aggregation response to arachidonic acid lend support to reevaluating the benefit of aspirin in larger trials with a clearly defined cohort of individuals with recurrent miscarriage. |
Page: 1